PIN26 COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION: CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE

Autor:	D Sangani
Rok vydání:	2010
Předmět:	medicine.medical_specialty Latent tuberculosis business.industry Health Policy Public Health Environmental and Occupational Health Cost-effectiveness analysis Pyrazinamide medicine.disease ISONIAZID/RIFAMPIN Internal medicine Medicine business health care economics and organizations medicine.drug
Zdroj:	Value in Health. 13(3)
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)72933-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876393f5c7d7c72d1801a4f4ad6ca4f8 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text